Bronchoscopy Clinical Trials

4 recruiting

Bronchoscopy Trials at a Glance

7 actively recruiting trials for bronchoscopy are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Athens, Bethesda, and Golnik. Lead sponsors running bronchoscopy studies include National Heart, Lung, and Blood Institute (NHLBI), Ruijin Hospital, and Menzies School of Health Research, Charles Darwin University.

Browse bronchoscopy trials by phase

About Bronchoscopy Clinical Trials

Looking for clinical trials for Bronchoscopy? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bronchoscopy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bronchoscopy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Collection of Lung Fluid and Tissue Samples for Research

Respiratory Tract DiseasesBronchoscopyLeukocyte Disorders
National Heart, Lung, and Blood Institute (NHLBI)550 enrolled1 locationNCT00471250
Recruiting
Not Applicable

AI-Driven Autonomous Registration in Robotic Bronchoscopy

Lung NodulesBronchoscopyLocalization Efficiency
Ruijin Hospital20 enrolled1 locationNCT07368829
Recruiting

Shape-Sensing Robotic-Assisted Bronchoscopy for Diagnosis of Peripheral Pulmonary Nodules in Korea

Lung CancersPulmonary NodulesLung Nodules+2 more
Ulsan University Hospital100 enrolled1 locationNCT07057648
Recruiting
Not Applicable

Robotic-assisted Bronchoscopy Under Moderate Sedation With Propofol

BronchoscopyPropofolLung Lesions+2 more
University of Zurich30 enrolled1 locationNCT07006311
Recruiting
Not Applicable

High - Flow Nasal Cannula Versus Conventional Nasal Cannula During Endobronchial Ultrasound Procedure

Hypoxemia During EBUS Bronchoscopy
The University Clinic of Pulmonary and Allergic Diseases Golnik150 enrolled4 locationsNCT06637280
Recruiting

Flexible Bronchoscopy Insufflated and High-Flow Nasal Oxygen Pilot Trial in Children

Hypoxemia during Flexible Bronchoscopy
University of Queensland80 enrolled2 locationsACTRN12621001635853
Recruiting

A cohort study to examine the effect of 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine (PHiD-CV, Synflorix, Registered Trademark) on the frequency of non-typeable Haemophilus influenzae (NTHi) infection in the upper and lower airways of children

non-typeable Haemophilus influenzae (NTHi) infectionChildren at risk of chronic lung disease and undergoing bronchoscopy
Menzies School of Health Research, Charles Darwin University316 enrolled2 locationsACTRN12614000743662